Gain a clear understanding of how the Inflation Reduction Act (IRA) is reshaping Medicare drug pricing and the broader pharmaceutical policy landscape in the United States. This white paper explores the fundamentals of the Medicare Drug Price Negotiation Program, including how drugs are selected, how negotiated prices are determined, and the implications for manufacturers, investors, payers, providers, and patients. Covering the first negotiation cycles, recent policy developments, and emerging future considerations, it provides an accessible overview of one of the most significant healthcare policy reforms in decades. Download now to stay informed on the evolving future of Medicare drug pricing and pharmaceutical policy.
Explore how real-world data (RWD) is transforming healthcare and life sciences in Charting the Landscape of Real-World Data in the U.S. by Polygon Health Analytics. This white paper maps key data sources, highlights practical applications across sectors, and addresses challenges in access, quality, and analytics. Whether you’re a researcher, clinician, policymaker, or data strategist, this guide offers actionable insights and best practices for leveraging RWD to drive innovation, equity, and evidence-based decisions. Download now to stay ahead in the evolving data-driven healthcare ecosystem.
